You are here

Industry News

Advamed Smart Brief

December 11, 2018
Viveve has priced a follow-on offering of 13.3 million shares at $1.50 apiece in hopes of raising $20 million.  -More
December 11, 2018
Edwards Lifesciences and Bay Labs have entered a partnership to improve heart disease detection through multiple initiatives, -More
December 11, 2018
A prospectus has been filed by Biocept for a public offering of approximately 9.7 millions shares of common stock and warrant -More
December 11, 2018
Fresenius Medical Care has made a number of investments in renal hospitals and dialysis centers in China, including the purch -More
December 11, 2018
EarlySense has agreed to integrate its contact-free heart rate and respiratory rate sensing technology into Hill-Rom's Centre -More
December 11, 2018
2019 promises to be an interesting year!
December 11, 2018
A global registry has been launched by Cerenovus for the collection and analysis of stroke-inducing blood clots removed using -More
December 11, 2018
A team of researchers from the University of Hartford and the University of Connecticut has developed a biosensor chip -- bui -More
December 11, 2018
Hologic has announced the US launch of its next-generation Omni hysteroscope after it received 510(k) clearance from the FDA  -More
December 11, 2018
Pear Therapeutics has secured clearance from the FDA to market its reSET-O mobile app for use in increasing retention of indi -More

Industry News

RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...